Genomic Expression Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 16
Employees
  • Latest Deal Type
  • Series A
  • (In Progress)
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 9

Genomic Expression General Information

Description

Developer of commercial-stage RNA Platform intended to provide cures in cancer and infectious diseases. The company's platform enables a paradigm shift from one disease, one marker and one drug to one patient to many markers and multiple treatment options that go beyond drugs and based on validation in women's cancer by testing and treating accordingly can prolong life for most patients and currently validated in women's cancer and COVID19 in FFPE, blood, and saliva, thereby helping doctors and medical practitioners with the design of mRNA vaccines as well as the design of sophisticated combinatorial clinical studies where one drug won't cure cancer but 2 or 3 combos could.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 100 Cummings Center
  • Suite 451C
  • Beverly, MA 01915
  • United States
+1 (646) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomic Expression Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) $20M 000.00 In Progress Generating Revenue
6. Secondary Transaction - Private 00.00 Completed Profitable
5. Grant 03-Jan-2018 00.00 00.00 Completed Generating Revenue
4. Accelerator/Incubator 21-Aug-2016 00000 00.00 Completed Generating Revenue
3. Later Stage VC 07-May-2015 000 00.00 Completed Generating Revenue
2. Grant 18-Mar-2015 $1.1M $200K Completed Generating Revenue
1. Early Stage VC 01-Jan-2012 $200K $200K Completed Generating Revenue
To view Genomic Expression’s complete valuation and funding history, request access »

Genomic Expression Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of commercial-stage RNA Platform intended to provide cures in cancer and infectious diseases. The company's pl
Diagnostic Equipment
Beverly, MA
16 As of 2021
000.00
000000 0 000.00

00000000

re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
0000000000 000000000
Thousand Oaks, CA
0 As of 0000
000.00
00.00 0000-00-00
00000000 000.00

00000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
0000000000 000000000
Irvine, CA
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genomic Expression Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LungLife AI Formerly VC-backed Thousand Oaks, CA 0 000.00 00000000 000.00
00000000 Pending Transaction (M&A) Irvine, CA 00 000.00 000000000 000.00
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
00000000000 Venture Capital-Backed Rockville, MD 00 00.000 000000000000 00.000
00000 Venture Capital-Backed Menlo Park, CA 000 000 000000&0 000
You’re viewing 5 of 51 competitors. Get the full list »

Genomic Expression Executive Team (13)

Name Title Board Seat Contact Info
Gitte Pedersen Co-Founder, President, Chief Executive Officer & Board Member
Morten Pedersen Ph.D Co-Founder, Chief Science Officer, Chief Technology Officer & Board Member
Gyorgy Abel Medical Director
Jesper Zeuthen Co-Founder, Independent Consultant & Chief Medical Officer
Bill Southworth Vice President of Data
You’re viewing 5 of 13 executive team members. Get the full list »

Genomic Expression Board Members (5)

Name Representing Role Since
Dan Adams Genomic Expression Board Member 000 0000
Gitte Pedersen Genomic Expression Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Kirsten Dinesen Genomic Expression Founding Board Member 000 0000
Melina Fan Genomic Expression Board Member 000 0000
Morten Pedersen Ph.D Genomic Expression Co-Founder, Chief Science Officer, Chief Technology Officer & Board Member 000 0000
To view Genomic Expression’s complete board members history, request access »

Genomic Expression Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomic Expression Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
North Shore InnoVentures Accelerator/Incubator 000 0000 000000 0
Al Sparks Angel (individual) Minority 000 0000 000000 0
Kim Tennican Angel (individual) Minority 000 0000 000000 0
Mette Rotbøll Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »